US-based Tivorsan Pharmaceuticals specializes in protein therapeutics for neuromuscular disorders.
Tivorsan Pharmaceuticals, founded in Providence, United States, is dedicated to developing protein therapeutics aimed at treating neuromuscular disorders. The company's core mission is to improve the quality of life for patients suffering from these debilitating conditions through innovative medical solutions. Tivorsan's primary focus is on leveraging its proprietary technology to create effective treatments that address the underlying causes of neuromuscular diseases.
Notable figures affiliated with Tivorsan Pharmaceuticals include leading scientists and industry experts who contribute to its research and development efforts. The company has attracted significant investment from venture capital firms specializing in biotech and pharmaceuticals. Key achievements include advancing its lead therapeutic candidates through critical stages of preclinical and clinical development, demonstrating promising results. Tivorsan's impact lies in its potential to transform the treatment landscape for neuromuscular disorders, offering hope to patients and families affected by these challenging conditions.
Tivorsan Pharmaceuticals' most recent funding round was for $4.5M (USD) in March 2017.
As of Mar 17, 2017, Tivorsan Pharmaceuticals has disclosed funding of $13.3M (USD).

Osprey Pharmaceuticals USA
ospreypharma.com
Myotherix

Tigris Pharmaceuticals
tigrispharma.com

Tulavi Therapeutics
tulavi.com

Tarsus Pharmaceuticals
tarsusrx.com

Novoron Bioscience
novoron.com

Theracos
theracos.com

WinSanTor
winsantor.com

Pharmatrophix
pharmatrophix.com

NeuroPro Therapeutics
Thesan Pharmaceuticals
thesanpharma.com

Terns Pharmaceuticals
ternspharma.com

Tavros Therapeutics

Valitor
valitorbio.com
VersaPeutics
versapeutics.com
Marinus Pharmaceuticals
marinuspharma.com